2-(Azidomethyl)arylboronic acids in the synthesis of coumarin-type compounds

Synthesis

Volumn , Issue 10, 2009, Pages 1673-1682

  Naumov, Mikael I ^a   Nuchev, Alexander V ^a   Sitnikov, Nikolay S ^a   Malysheva, Yulia B ^a   Shavyrin, Andrew S ^b   Beletskaya, Irina P ^c   Gavryushin, Andrei E ^d   Combes, Sebastien ^e   Fedorov, Alexey Yu ^a  

^a LOBACHEVSKY STATE UNIVERSITY OF NIZHNY NOVGOROD   (Russian Federation)

^b G A RAZUVAEV INSTITUTE OF ORGANOMETALLIC CHEMISTRY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF MUNICH   (Germany)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Arylation; Azides; Coumarins; Cross coupling; Cycloaddition

Indexed keywords

ARYLATION; ARYLATION REACTIONS; ARYLBORONIC ACIDS; AZIDES; COUMARINS; CROSS-COUPLING; GOOD YIELD; NEOFLAVONOID COMPOUNDS; ONE-POT REACTION; ORGANOBORON; PALLADIUM-CATALYZED CROSS-COUPLING; SUZUKI REACTION;

AROMATIC COMPOUNDS; NITROGEN COMPOUNDS; PALLADIUM; SYNTHESIS (CHEMICAL);

ACIDS;

1,4 TRIAZOLE; 2 (AZIDOMETHYL)ARYLBORONIC ACID DERIVATIVE; 3 [2 (AZIDOMETHYL)ARYL] 4HYDROXYCOUMARIN DERIVATIVE; 4 [2 (AZIDOMETHYL)ARYL] COUMARIN DERIVATIVE; 4 HYDROXYCOUMARIN DERIVATIVE; 4 TRIFLUOROMETHYLSULFONYLOXYCOUMARIN DERIVATIVE; [4,3 C] ISOQUINOLINO COUMARIN DERIVATIVE; ALKYNE; BORONIC ACID DERIVATIVE; COUMARIN DERIVATIVE; ISOFLAVONOID; PALLADIUM; TRIAZOLE; UNCLASSIFIED DRUG;

ARTICLE; ARYLATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CROSS COUPLING REACTION; CYCLOADDITION; ONE POT SYNTHESIS; SUZUKI REACTION; SYNTHESIS;

EID: 67650089579     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0028-1088058     Document Type: Article

References (75)

1. (a) Donnelly, D. M. X.; Boland, G. In The Flavonoids: Advances in Research since 1986; Horborne, J. B., Ed.; Chapman and Hall: London, 1994, 239-258.
2. (b) Barton, D. H. D.; Donnelly, D. M. X.; Finet, J.-P.; Guiry, P. G. J. Chem. Soc., Perkin Trans. 1 1992, 1365.
3. (c) Combes, S.; Finet, J.-P.; Siri, D. J. Chem. Soc., Perkin Trans. 1 2002, 38.
4. (a) Petit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D. Experientia 1989, 45, 209.
5. (b) Petit, G. R.; Singh, S. B.; Boyd, M. R.; Hamel, E.; Petit, R. K.; Schmidt, J. M.; Hogan, F. J. J. Med. Chem. 1995, 38, 1666.
6. (c) Nam, N.-H. Curr. Med. Chem. 2003, 10, 1697.
7. (d) Tron, G. C.; Pirali, T.; Sorba, G.; Pagliai, F.; Busacca, S.; Genazzani, A. J. Med. Chem. 2006, 49, 3033.
8. (e) Chaudhary, A.; Pandeya, S. N.; Kumar, P.; Sharma, P. P.; Gupta, S.; Soni, N.; Verma, K. K.; Bhardwaj, G. Mini Rev. Med. Chem. 2007, 7, 1186.
9. Taechowisan, T.; Lu, C.; Chen, Y.; Lumyong, S. J. Cancer Res. Ther. 2007, 3, 86.
10. (a) Bailly, C.; Bal, C.; Barbier, P.; Combes, S.; Finet, J.-P.; Hildebrand, M.-P.; Peyrot, V.; Wattez, N. J. Med. Chem. 2003, 46, 5437.
11. (b) Rappl, C.; Barbier, P.; Bourgarel-Rey, V.; Gregoire, C.; Gilli, R.; Carre, M.; Combes, S.; Finet, J.-P.; Peyrot, V. Biochem. 2006, 45, 9210
12. (a) Oldfield, M. F.; Chen, L.; Botting, N. P. Tetrahedron 2004, 60, 1887.
13. (b) Dixon, R. A.; Ferreira, D. Phytochemistry 2002, 16, 205.
14. (a) Adlercreutz, H. Lancet Oncol. 2002, 3, 364.
15. (b) Morrisey, C.; Watson, R. W. G. Curr. Drug Targets 2003, 4, 231.
16. Anthony, M. S. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1245.
17. Stark, A.; Madar, Z. J. Pediatr. Endocrinol. Metab. 2002, 15, 561.
18. Yamaguchi, M. Health Sci. 2002, 48, 209.
19. (a) Soleas, G. J.; Diamandis, E. P.; Goldberg, D. M. Clin. Biochem. 1997, 30, 91.
20. (b) Burns, J.; Yokota, T.; Ashihara, H.; Lean, M. E. J.; Crozier, A. J. Agric. Food Chem. 2002, 50, 3337.
21. (c) Roberti, M.; Pizzirani, D.; Simoni, D.; Rondanin, R.; Baruchello, R.; Bonora, C.; Buscemi, F.; Grimaudo, S.; Tolomeo, M. J. Med. Chem. 2003, 46, 3546.
22. Pace-Asciak, C. R.; Hahn, S.; Diamandis, E. P.; Soleas, G.; Goldberg, D. M. Clin. Chem. Acta 1995, 235, 207.
23. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. H. S.; Farnworth, R. N.; Kinghorn, A. D.; Metha, R. G.; Moon, R. C.; Pezzuto, J. M. Science 1997, 275, 218.
24. (a) Cushman, M.; Nagaratham, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. J. Med. Chem. 1991, 34, 2579.
25. (b) Ohsumi, K.; Hatanaka, T.; Fujita, K.; Nakagawa, R.; Fukuda, Y.; Nihei, Y.; Suga, Y.; Morinaga, Y.; Akiyama, Y.; Tsuji, T. Bioorg. Med. Chem. Lett. 1998, 8, 3153.
26. (a) Lewis, R. J. Sax's Dangerous Properties of Industrial Materials; Van Nostrand Reinhold: New York, 1992.
27. (b) Lenga, R. E. The Sigma-Aldrich Library of Chemical Safety; Sigma-Aldrich: Milwaukee, 1988.
28. (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
29. (b) Suzuki, A. J. Organomet. Chem. 1999, 576, 147.
30. (c) Llord-Williams, P.; Giralt, E. Chem. Soc. Rev. 2001, 30, 145.
31. (d) Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.; Lamaire, M. Chem. Rev. 2002, 102, 1359.
32. Morgan, J.; Pinhey, J. T. J. Chem. Soc., Perkin Trans. 1 1990, 715.
33. Finet, J.-P. Ligand Coupling Reactions with Heteroatomic Compounds; Pergamon Press: Oxford, 1998.
34. (a) Pinhey, J. T. In Comprehensive Organometallic Chemistry II, Vol. 11; Abel, E. V.; Stone, F. G. A.; Wilkinson, G., Eds.; Pergamon Press: Oxford, 1995, Chap. 11.11, 461-485.
35. (b) Finet, J.-P. In Comprehensive Organometallic Chemistry III, Vol. 9; Crabtree, R. H.; Mingos, D. M. P., Eds.; Elsevier: Oxford, 2006, Chap. 9.9, 381-424.
36. (c) Elliot, C. I.; Konopelski, J. P. Tetrahedron 2001, 57, 5683.
37. (d) Kano, T.; Saito, S. In Main Group Metals in Organic Synthesis I, Vol. 2; Yamamoto, H.; Oshima, K., Eds.; Wiley-VCH: Weinheim, 2004, 721-751.
38. (a) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234.
39. (b) Herrmann, W. A. Angew. Chem. Int. Ed. 2002, 41, 1290.
40. (c) Miura, M.; Nomura, M. Top. Curr. Chem. 2002, 219, 211.
41. (d) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174.
42. (e) Kakiuchi, F.; Kochi, T. Synthesis 2008, 3013.
43. (a) Barton, D. H. R.; Donnelly, D. M. X.; Finet, J.-P.; Guiry, P. J. Tetrahedron Lett. 1990, 31, 7449.
44. (b) Donnelly, D. M. X.; Molloy, D. J.; Reilly, J. P.; Finet, J.-P. J. Chem. Soc., Perkin Trans. 1 1995, 2531.
45. (c) Suginome, H.; Orito, K.; Yorita, K.; Ishikawa, M.; Shimoyama, N.; Sasaki, T. J. Org. Chem. 1995, 60, 3052.
46. (d) Orito, K.; Sasaki, T.; Suginome, H. J. Org. Chem. 1995, 60, 6208.
47. (e) Konopelsky, J. P.; Hottenroth, J. M.; Oltra, H. M.; Veliz, E. A.; Yang, Z.-C. Synlett 1996, 609.
48. (f) Naumov, M. I.; Sutirin, S. A.; Shavirin, A. S.; Ganina, O. G.; Bourgarel-Rey, V.; Beletskaya, I. P.; Finet, J.-P.; Fedorov, A. Yu. J. Org. Chem. 2007, 72, 3293.
49. Sviridov, S. I.; Vasil'ev, A. A.; Sergovskaya, N. L.; Chirskaya, M. V.; Shorshnev, S. V. Tetrahedron 2006, 62, 2639.
50. Brown, B. R. The Organic Chemistry of Aliphatic Nitrogen Compounds; Clarendon: Oxford, 1994, 644-667.
51. (a) Knochel, P.; Dohle, W.; Gommermann, N.; Kneisel, F. F.; Kopp, F.; Korn, T.; Sapountzis, I.; Vu, V. A. Angew. Chem. Int. Ed. 2003, 42, 4302.
52. (b) Knochel, P.; Krasovskiy, A.; Sapountzis, I. In Handbook of Functionalized Organometallics, Vol. 1; Knochel, P., Ed.; Wiley-VCH: Weinheim, 2005, 109-172.
53. (c) Krasovskiy, A.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 3333.
54. (d) Krasovskiy, A.; Malakhov, V.; Gavryushin, A.; Knochel, P. Angew. Chem. Int. Ed. 2006, 45, 6040.
55. Wang, X.-J.; Sun, X.; Zhang, L.; Xu, Y.; Krishnamurthy, D.; Senanayake, C. H. Org. Lett. 2006, 8, 305.
56. (a) Fedorov, A. Yu.; Carrara, F.; Finet, J.-P. Tetrahedron Lett. 2001, 42, 5875.
57. (b) Bolshakov, A. V.; Ganina, O. G.; Shavirin, A. S.; Kurski, Yu. A.; Finet, J.-P.; Fedorov, A. Yu. Tetrahedron Lett. 2002, 43, 8245.
58. Naumov, M. I.; Ganina, O. G.; Shavirin, A. S.; Beletskaya, I. P.; Finet, J.-P.; Fedorov, A. Yu. Synthesis 2005, 1178.
59. Fedorov, A. Yu.; Shchepalov, A. A.; Bol'shakov, A. V.; Shavyrin, A. S.; Kurskii, Yu. A.; Finet, J.-P.; Zelentsov, S. V. Russ. Chem. Bull. Int. Ed. 2004, 53, 370.
60. Oae, S. Croat. Chem. Acta 1986, 59, 129.
61. Suzuki, H.; Matano, Y. Organobismuth Chemistry; Elsevier: Amsterdam, 2001.
62. Grushin, V. V. Chem. Soc. Rev. 2000, 29, 315.
63. Fedorov, A. Yu.; Finet, J.-P. Eur. J. Org. Chem. 2004, 2040.
64. Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88, 297.
65. (a) Foch, I.; Parkanyi, L.; Besenyei, G.; Simandi, L. I.; Kalman, A. J. Chem. Soc., Dalton Trans. 1999, 293.
66. (b) Nakamura, I.; Yamamoto, Y. Chem. Rev. 2004, 104, 2127.
67. (a) Beletskaya, I. P.; Ganina, O. G.; Tsvetkov, A. V.; Fedorov, A. Yu.; Finet, J.-P. Synlett 2004, 2797.
68. (b) Ganina, O. G.; Daras, E.; Bourgarel-Rey, V.; Peyrot, V.; Andresyuk, A. N.; Finet, J.-P.; Fedorov, A. Yu.; Beletskaya, I. P.; Combes, S. Bioorg. Med. Chem. 2008, 16, 8806.
69. Tornøe, C. W.; Christensen, C.; Mendal, M. J. Org. Chem. 2002, 67, 3057.
70. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2596.
71. (a) Bock, V. D.; Hiemstra, H.; van Maarseveen, J. H. Eur. J. Org. Chem. 2006, 51.
72. (b) Wu, P.; Fokin, V. V. Aldrichimica Acta 2007, 40, 7.
73. Boronic acids 21a-c, like their precursors 4a,b coexist with anhydride forms of boronic acids with different degree of oligomerization. The NMR spectra of 21a-c derivatives purified by crystallization were rather complicated. On the other hand, when compounds 21a-c were isolated by column chromatography on silica gel, the NMR spectra of these products became almost fine due to the cleavage of the ether bonds in the associates.
74. (a) Boland, G. M.; Donnelly, D. M. X.; Finet, J.-P.; Rea, M. D. J. Chem. Soc., Perkin Trans. 1 1996, 2591.
75. (b) Donnelly, D. M. X.; Finet, J.-P.; Guiry, P. J.; Rea, M. D. Synth. Commun. 1999, 29, 2719.